At HIPRA we are introducing a new solution against Nodavirus in the Mediterranean: ICTHIOVAC® VNN an inactivated injectable vaccine with promising results.
Introducing a new solution for sea bass against VNN
魚
![Banner-news-icthiovac-vnn](https://static-web.hipra.com/styles/3_1_1920px_width/s3/2021-10/Banner-news-icthiovac-vnn.jpeg?itok=hUeGFbYp)
![news3](https://static-web.hipra.com/styles/16_9_768px_width_/s3/2021-09/icthiovac-vnn2.jpeg?itok=WO2Hjf_h)
ICTHIOVAC® VNN provides the fish farming industry with an effective tool for the prevention of Nodavirus, a disease considered to be the greatest challenge to Mediterranean aquaculture in the coming years, causing high levels of mortality and reduced growth.
Contains an advanced adjuvant that enhances immunity
ICTHIOVAC® VNN is adjuvanted with AQUAMUN, a non-mineral oil adjuvant that ensures long-lasting protection and enhances the specific immune response, whilst adverse reactions are minimized.
By registering ICTHIOVAC® VNN, a new solution against Nodavirus for sea bass, HIPRA reaffirms its commitment to prevention in Mediterranean aquaculture, providing innovation to the animal health industry.